f******y
发帖数: 830 | 1 This is the news on Oct 10th, 2014 (FRIDAY) when Harvoni is approved. What
you want to keep an eye on is how ABBV's drug will be priced compare to
gilead's $94,500.
++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++
++
http://www.nytimes.com/2014/10/11/business/harvoni-a-hepatitis-
The first complete treatment for hepatitis C that requires taking only a
once-a-day pill won approval Friday from the Food and Drug Administration.
The drug, called Harvoni from Gilead Sciences, could shorten the duration of
treatment and provide the first all-oral regimen for many patients.
The new drug also appears to be a bit less expensive for some patients than
Gilead’s existing blockbuster hepatitis C drug, Sovaldi, which has become
the poster child for those complaining that the cost of medicines is out of
control.
Sovaldi costs $1,000 a pill, or $84,000 for a typical 12-week course of
treatment, but it must be used with other drugs. Harvoni is even more
expensive at $1,125 a pill, or $94,500 for a 12-week course of treatment.
But that is roughly in line with the total cost for Sovaldi and the drugs
used with it. Many patients will be able to take Harvoni for only eight
weeks, at a cost of about $63,000.
This will probably not mollify insurance companies and Medicaid programs,
many of which are restricting the use of Sovaldi to the most seriously ill
patients. | a***n
发帖数: 623 | | f******y
发帖数: 830 | 3 good, what 's your prediction if abbv give s 30% discount ? what do you
think market will react?
【在 a***n 的大作中提到】
: 早就知道了。
| S********9
发帖数: 1121 | 4 so what?你是病人，你会在乎这点钱还是在乎你的命啊，病人肯定要用最好的药，abbv
的差gild几条街呢，副作用也大的多。
穷人囚犯反正药都是有别人买单，讲人权的话肯定要给最好的药。
现在价钱基本上abbv已经price in | b**********9
发帖数: 442 | | p********y
发帖数: 5044 | 6 side effects, lz!!! price is not the main issue for drugs. | j********8
发帖数: 2201 | 7 如果股市这么容易预测，就没有人亏钱了。
【在 b**********9 的大作中提到】
: mm肯定会利用消息打压股价，拉低吸筹
|
|
